Should I get treatment at a comprehensive cancer center for Prostate Cancer

Should You Get Treatment at a Comprehensive Cancer Center for Prostate Cancer?

Based on the evidence from leading prostate cancer experts, yes—seeking care at a comprehensive cancer center is strongly recommended, especially if you have advanced disease or complex treatment decisions ahead.

Why Comprehensive Cancer Centers Matter for Prostate Cancer

Access to Specialized Expertise

According to Andrew Armstrong, MD (a leading prostate cancer researcher), most men in community practices—especially in rural and urology-only settings—are not getting adequate testing and personalized treatment planning. Comprehensive cancer centers typically have:

• Genitourinary (GU) medical oncologists who specialize exclusively in prostate cancer
• Multidisciplinary teams including radiation oncologists, pathologists, and genetic counselors
• Access to clinical trials testing cutting-edge therapies
• Molecular tumor boards that review complex cases

Personalized Testing & Biomarker Analysis

Comprehensive centers can order and interpret the advanced tests that guide modern prostate cancer treatment:

• Genetic testing (DNA and RNA sequencing) to identify actionable mutations like BRCA, CDK12, or mismatch repair deficiency—which identify about 20% of patients for targeted drug options
• Liquid biopsies (blood tests for circulating tumor DNA) to monitor disease and detect resistance
• Multi-omic analysis (examining your cancer from multiple biological perspectives) to match you with the most effective treatments
• Spatial analysis and immunohistochemistry (IHC) to understand your tumor's immune microenvironment

According to Rana McKay, MD and the BostonGene team, this comprehensive testing approach is essential because treatment decisions based on a single test have confidence risks—validation through multiple testing methods is more reliable.

Real-World Impact: What the Evidence Shows

Rick Stanton, a prostate cancer patient who received comprehensive care, discovered through DNA sequencing that he had CDK12 mutations targetable by FDA-approved drugs like Olaparib—something he "would never have known" without this testing. This finding aligned with NCCN Guidelines recommendations for testing DNA repair genes.

Similarly, Brian McCloskey worked with a comprehensive cancer center team to:

• Aggregate 17 different treatment options from multiple sources
• Have his oncologist narrow these to 8, then 3 evidence-based choices
• Access a clinical trial combining cabozantinib (a targeted drug) with nivolumab (immunotherapy)

What to Look For in a Comprehensive Cancer Center

According to the evidence, prioritize centers that offer:

1. Dedicated GU medical oncologists (not general oncologists)
2. Molecular profiling programs as standard of care
3. Clinical trial access for advanced or resistant disease
4. Multidisciplinary tumor boards that review cases collaboratively
5. Endocrinology support if you're on hormone deprivation therapy (to manage side effects)

Important Considerations

If you have localized (early-stage) prostate cancer, a comprehensive center is still valuable for:

• Accurate Gleason scoring and risk stratification
• Discussing active surveillance vs. surgery vs. radiation with specialists
• Genetic testing to identify hereditary cancer risk

If you have advanced or castrate-resistant prostate cancer, comprehensive center care becomes even more critical because:

• Treatment options are more complex and individualized
• Resistance patterns require sophisticated biomarker analysis
• Clinical trials may offer access to newer therapies

Questions to Ask When Choosing a Center

Based on the evidence, ask potential centers:

1. "Do you routinely perform DNA and RNA sequencing on prostate cancer patients?"
2. "Do you have a genitourinary medical oncologist on staff who specializes in prostate cancer?"
3. "What clinical trials are currently available for my stage of disease?"
4. "Can you perform liquid biopsies and multi-omic analysis to guide treatment?"
5. "Do you have a multidisciplinary tumor board that reviews complex cases?"

---

Bottom Line

According to the CancerPatientLab webinars featuring experts like Andrew Armstrong, Rana McKay, and Oliver Sartor, MD, comprehensive cancer centers provide access to the testing, expertise, and treatment options that lead to better outcomes. The difference between community care and specialized center care can be significant—especially in identifying which treatments will actually work for YOUR specific cancer biology.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.